Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1326393
[patent_doc_number] => 06602980
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-05
[patent_title] => 'Collagen type III synthetic peptides for collagen resorption assays'
[patent_app_type] => B1
[patent_app_number] => 10/009999
[patent_app_country] => US
[patent_app_date] => 2002-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6346
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/602/06602980.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009999
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009999 | Collagen type III synthetic peptides for collagen resorption assays | Jun 30, 2002 | Issued |
Array
(
[id] => 6402742
[patent_doc_number] => 20020182227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Treatment of virus using chelator and antiviral agent'
[patent_app_type] => new
[patent_app_number] => 10/159723
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1109
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10159723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/159723 | Treatment of virus using chelator and antiviral agent | May 28, 2002 | Abandoned |
Array
(
[id] => 6402671
[patent_doc_number] => 20020182217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Time release chelators'
[patent_app_type] => new
[patent_app_number] => 10/159434
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 900
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182217.pdf
[firstpage_image] =>[orig_patent_app_number] => 10159434
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/159434 | Time release chelators | May 28, 2002 | Abandoned |
10/049579 | Pharmaceutical product for the treatment of viral infections, in particular of the human immunodeficiency virus (hiv) | May 14, 2002 | Abandoned |
Array
(
[id] => 6730064
[patent_doc_number] => 20030186254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Regulation of HIV-Tat and Nef by PAK4 kinase and its binding partners and methods of identifying modulators thereof'
[patent_app_type] => new
[patent_app_number] => 10/134102
[patent_app_country] => US
[patent_app_date] => 2002-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8228
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20030186254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134102
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134102 | Regulation of HIV-Tat and Nef by PAK4 kinase and its binding partners and methods of identifying modulators thereof | Apr 28, 2002 | Abandoned |
09/980576 | Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations | Apr 10, 2002 | Abandoned |
Array
(
[id] => 1271640
[patent_doc_number] => 06653443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-25
[patent_title] => 'Multimerization of HIV-1 Vif protein as a therapeutic target'
[patent_app_type] => B2
[patent_app_number] => 10/118575
[patent_app_country] => US
[patent_app_date] => 2002-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14651
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653443.pdf
[firstpage_image] =>[orig_patent_app_number] => 10118575
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/118575 | Multimerization of HIV-1 Vif protein as a therapeutic target | Apr 7, 2002 | Issued |
Array
(
[id] => 6791911
[patent_doc_number] => 20030087255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Peptides which stimulate the immune response and tissue regeneration'
[patent_app_type] => new
[patent_app_number] => 10/116391
[patent_app_country] => US
[patent_app_date] => 2002-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7580
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20030087255.pdf
[firstpage_image] =>[orig_patent_app_number] => 10116391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/116391 | Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration | Apr 3, 2002 | Issued |
Array
(
[id] => 1213327
[patent_doc_number] => 06705556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-03-16
[patent_title] => 'Composition and method for inducing tolerance to viral infection in aquatic animals'
[patent_app_type] => B2
[patent_app_number] => 10/115653
[patent_app_country] => US
[patent_app_date] => 2002-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 15391
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/705/06705556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10115653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/115653 | Composition and method for inducing tolerance to viral infection in aquatic animals | Mar 27, 2002 | Issued |
Array
(
[id] => 1261256
[patent_doc_number] => 06664099
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Method for the preservation of viruses and mycoplasma'
[patent_app_type] => B1
[patent_app_number] => 09/980698
[patent_app_country] => US
[patent_app_date] => 2002-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5879
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664099.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980698
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980698 | Method for the preservation of viruses and mycoplasma | Mar 7, 2002 | Issued |
Array
(
[id] => 1122945
[patent_doc_number] => 06794129
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-21
[patent_title] => 'Method for measuring anti-protease resistance of HIV-2 in a patient'
[patent_app_type] => B1
[patent_app_number] => 09/980777
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5204
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/794/06794129.pdf
[firstpage_image] =>[orig_patent_app_number] => 09980777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/980777 | Method for measuring anti-protease resistance of HIV-2 in a patient | Feb 19, 2002 | Issued |
Array
(
[id] => 6305964
[patent_doc_number] => 20020094524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Compositions and methods for inhibiting HIV infection'
[patent_app_type] => new
[patent_app_number] => 10/077507
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8913
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20020094524.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077507 | Compositions and methods for inhibiting HIV infection | Feb 14, 2002 | Abandoned |
Array
(
[id] => 6174525
[patent_doc_number] => 20020155123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Compositions and methods for inhibiting HIV infection'
[patent_app_type] => new
[patent_app_number] => 10/077480
[patent_app_country] => US
[patent_app_date] => 2002-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8928
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20020155123.pdf
[firstpage_image] =>[orig_patent_app_number] => 10077480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/077480 | Neurokinin receptor antagonists and methods of use thereof for inhibiting HIV infection | Feb 14, 2002 | Issued |
Array
(
[id] => 6405896
[patent_doc_number] => 20020182639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Synthetic peptides for cartilage resorption assays'
[patent_app_type] => new
[patent_app_number] => 10/073679
[patent_app_country] => US
[patent_app_date] => 2002-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4156
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20020182639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10073679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/073679 | Synthetic peptides of type II collagen for cartilage resorption assays | Feb 10, 2002 | Issued |
Array
(
[id] => 1285729
[patent_doc_number] => 06635285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-10-21
[patent_title] => 'Shark cartilage extract: process of making, methods of using, and compositions thereof'
[patent_app_type] => B2
[patent_app_number] => 10/068950
[patent_app_country] => US
[patent_app_date] => 2002-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 48
[patent_no_of_words] => 23519
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068950 | Shark cartilage extract: process of making, methods of using, and compositions thereof | Feb 6, 2002 | Issued |
09/958654 | Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1protein | Feb 5, 2002 | Abandoned |
Array
(
[id] => 6869519
[patent_doc_number] => 20030082208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Protein having multiple antigen/epitope sequences and being immobilized'
[patent_app_type] => new
[patent_app_number] => 10/059271
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6394
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059271 | Protein having multiple antigen/epitope sequences and being immobilized | Jan 30, 2002 | Abandoned |
Array
(
[id] => 6683194
[patent_doc_number] => 20030119058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Method of assaying type III collagen degradation'
[patent_app_type] => new
[patent_app_number] => 10/058124
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10811
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10058124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/058124 | Method of assaying type III collagen degradation | Jan 28, 2002 | Abandoned |
Array
(
[id] => 6869832
[patent_doc_number] => 20030082521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Polypeptide inducing antibodies neutralizing HIV'
[patent_app_type] => new
[patent_app_number] => 10/040349
[patent_app_country] => US
[patent_app_date] => 2002-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7934
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040349
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040349 | Polypeptide inducing antibodies neutralizing HIV | Jan 6, 2002 | Issued |
Array
(
[id] => 6262489
[patent_doc_number] => 20020188107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-12
[patent_title] => 'Component of stem bromelain'
[patent_app_type] => new
[patent_app_number] => 10/029301
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12499
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20020188107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029301 | Component of stem bromelain | Dec 27, 2001 | Abandoned |